Literature DB >> 29921610

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.

Frederike C Oertel1, Joachim Havla2, Adriana Roca-Fernández3, Nathaniel Lizak1,4, Hanna Zimmermann1, Seyedamirhosein Motamedi1, Nadja Borisow1, Owen B White5, Judith Bellmann-Strobl1,6, Philipp Albrecht7, Klemens Ruprecht8, Sven Jarius9, Jacqueline Palace3, Maria Isabel Leite3, Tania Kuempfel2, Friedemann Paul10,6,8, Alexander U Brandt1,11.   

Abstract

OBJECTIVES: Neuromyelitis optica spectrum disorders (NMOSD) are inflammatory conditions of the central nervous system and an important differential diagnosis of multiple sclerosis (MS). Unlike MS, the course is usually relapsing, and it is unclear, if progressive neurodegeneration contributes to disability. Therefore, we aimed to investigate if progressive retinal neuroaxonal damage occurs in aquaporin4-antibody-seropositive NMOSD.
METHODS: Out of 157 patients with NMOSD screened, 94 eyes of 51 patients without optic neuritis (ON) during follow-up (F/U) and 56 eyes of 28 age-matched and sex-matched healthy controls (HC) were included (median F/U 2.3 years). The NMOSD cohort included 60 eyes without (EyeON -) and 34 eyes with a history of ON prior to enrolment (EyeON+). Peripapillary retinal nerve fibre layer thickness (pRNFL), fovea thickness (FT), volumes of the combined ganglion cell and inner plexiform layer (GCIP) and the inner nuclear layer (INL) and total macular volume (TMV) were acquired by optical coherence tomography (OCT).
RESULTS: At baseline, GCIP, FT and TMV were reduced in EyeON+ (GCIP p<2e-16; FT p=3.7e-4; TMV p=3.7e-12) and in EyeON - (GCIP p=0.002; FT p=0.040; TMV p=6.1e-6) compared with HC. Longitudinally, we observed GCIP thinning in EyeON- (p=0.044) but not in EyeON+. Seven patients had attacks during F/U; they presented pRNFL thickening compared with patients without attacks (p=0.003).
CONCLUSION: This study clearly shows GCIP loss independent of ON attacks in aquaporin4-antibody-seropositive NMOSD. Potential explanations for progressive GCIP thinning include primary retinopathy, drug-induced neurodegeneration and retrograde neuroaxonal degeneration from lesions or optic neuropathy. pRNFL thickening in the patients presenting with attacks during F/U might be indicative of pRNFL susceptibility to inflammation. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29921610     DOI: 10.1136/jnnp-2018-318382

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

Review 1.  Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies.

Authors:  Nadja Borisow; Kerstin Hellwig; Friedemann Paul
Journal:  EPMA J       Date:  2018-08-10       Impact factor: 6.543

2.  Peripapillary hyper-reflective ovoid mass-like structures (PHOMS) in AQP4-IgG-positive neuromyelitis optica spectrum disease (NMOSD) and MOG-IgG-associated disease (MOGAD).

Authors:  Jonathan A Gernert; Rebecca Wicklein; Benjamin Knier; Joachim Havla; Bernhard Hemmer; Tania Kümpfel
Journal:  J Neurol       Date:  2022-10-16       Impact factor: 6.682

Review 3.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

4.  Optic Neuritis-Independent Retinal Atrophy in Neuromyelitis Optica Spectrum Disorder.

Authors:  Angeliki G Filippatou; Eleni S Vasileiou; Yufan He; Kathryn C Fitzgerald; Grigorios Kalaitzidis; Jeffrey Lambe; Maureen A Mealy; Michael Levy; Yihao Liu; Jerry L Prince; Ellen M Mowry; Shiv Saidha; Peter A Calabresi; Elias S Sotirchos
Journal:  J Neuroophthalmol       Date:  2021-05-17       Impact factor: 4.415

5.  The Role of Optical Coherence Tomography in Differential Diagnosis of Multiple Sclerosis and Autoimmune Connective Tissue Diseases with CNS Involvement.

Authors:  Paula Wildner; Ewa Zydorczak; Magdalena Oset; Małgorzata Siger; Michał Wilczyński; Mariusz Stasiołek; Mariola Matysiak
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

Review 6.  Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.

Authors:  Nadja Borisow; Masahiro Mori; Satoshi Kuwabara; Michael Scheel; Friedemann Paul
Journal:  Front Neurol       Date:  2018-10-23       Impact factor: 4.003

7.  Rituximab during pregnancy in neuromyelitis optica: A case report.

Authors:  Jahir Miranda-Acuña; Erica Rivas-Rodríguez; Michael Levy; Mustafa Ansari; Roslynn Stone; Vivek Patel; Lilyana Amezcua
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-02-01

8.  Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.

Authors:  Valentin Juenger; Graham Cooper; Claudia Chien; Meera Chikermane; Frederike Cosima Oertel; Hanna Zimmermann; Klemens Ruprecht; Sven Jarius; Nadja Siebert; Joseph Kuchling; Athina Papadopoulou; Susanna Asseyer; Judith Bellmann-Strobl; Friedemann Paul; Alexander U Brandt; Michael Scheel
Journal:  Eur Radiol       Date:  2020-04-26       Impact factor: 5.315

9.  Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).

Authors:  Alexander U Brandt; Friedemann Paul; Svenja Specovius; Hanna G Zimmermann; Frederike Cosima Oertel; Claudia Chien; Charlotte Bereuter; Lawrence J Cook; Marco Aurélio Lana Peixoto; Mariana Andrade Fontenelle; Ho Jin Kim; Jae-Won Hyun; Su-Kyung Jung; Jacqueline Palace; Adriana Roca-Fernandez; Alejandro Rubio Diaz; Maria Isabel Leite; Srilakshmi M Sharma; Fereshte Ashtari; Rahele Kafieh; Alireza Dehghani; Mohsen Pourazizi; Lekha Pandit; Anitha Dcunha; Orhan Aktas; Marius Ringelstein; Philipp Albrecht; Eugene May; Caryl Tongco; Letizia Leocani; Marco Pisa; Marta Radaelli; Elena H Martinez-Lapiscina; Hadas Stiebel-Kalish; Mark Hellmann; Itay Lotan; Sasitorn Siritho; Jérôme de Seze; Thomas Senger; Joachim Havla; Romain Marignier; Caroline Tilikete; Alvaro Cobo Calvo; Denis Bernardi Bichuetti; Ivan Maynart Tavares; Nasrin Asgari; Kerstin Soelberg; Ayse Altintas; Rengin Yildirim; Uygur Tanriverdi; Anu Jacob; Saif Huda; Zoe Rimler; Allyson Reid; Yang Mao-Draayer; Ibis Soto de Castillo; Michael R Yeaman; Terry J Smith
Journal:  BMJ Open       Date:  2020-10-29       Impact factor: 2.692

10.  Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker.

Authors:  Orhan Aktas; Michael A Smith; William A Rees; Jeffrey L Bennett; Dewei She; Eliezer Katz; Bruce A C Cree
Journal:  Ann Neurol       Date:  2021-03-30       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.